» Articles » PMID: 20930846

MAPK Signalling in Cellular Metabolism: Stress or Wellness?

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2010 Oct 9
PMID 20930846
Citations 136
Authors
Affiliations
Soon will be listed here.
Abstract

Mitogen-activated protein kinase (MAPK) signalling occurs in response to almost any change in the extracellular or intracellular milieu that affects the metabolism of the cell, organ or the entire organism. MAPK-dependent signal transduction is required for physiological metabolic adaptation, but inappropriate MAPK signalling contributes to the development of several interdependent pathological traits, collectively known as metabolic syndrome. Metabolic syndrome leads to life-threatening clinical consequences, such as type 2 diabetes. This Review provides an overview of the MAPK-signalling mechanisms that underly basic cellular metabolism, discussing their link to disease.

Citing Articles

Choline metabolism disorder induced by Prevotella is a risk factor for endometrial cancer in women with polycystic ovary syndrome.

Chen P, Liu Q, Shi H, Liu Z, Yang X Mol Biol Rep. 2025; 52(1):285.

PMID: 40047940 DOI: 10.1007/s11033-025-10392-8.


Transcriptomics insights into glutamine on repairing of histamine-induced Yak rumen epithelial cells barrier damage in vitro.

Zhang X, Hu R, Wang Z, Wang J, Yue Z, Wu F BMC Genomics. 2025; 26(1):195.

PMID: 40000997 PMC: 11863408. DOI: 10.1186/s12864-025-11383-6.


Regulation and function of insulin and insulin-like growth factor receptor signalling.

Choi E, Duan C, Bai X Nat Rev Mol Cell Biol. 2025; .

PMID: 39930003 DOI: 10.1038/s41580-025-00826-3.


Effects of intrauterine extracellular vesicle microRNAs on embryonic gene expression in low-fertility cows.

Ichikawa R, Kimura K, Nakamura S, Ohkura S, Matsuyama S FASEB J. 2024; 38(20):e70116.

PMID: 39425543 PMC: 11580725. DOI: 10.1096/fj.202401728R.


Unraveling neuronal and metabolic alterations in neurofibromatosis type 1.

Botero V, Tomchik S J Neurodev Disord. 2024; 16(1):49.

PMID: 39217323 PMC: 11365184. DOI: 10.1186/s11689-024-09565-6.


References
1.
Hotamisligil G . Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010; 140(6):900-17. PMC: 2887297. DOI: 10.1016/j.cell.2010.02.034. View

2.
Antonescu C, Huang C, Niu W, Liu Z, Eyers P, Heidenreich K . Reduction of insulin-stimulated glucose uptake in L6 myotubes by the protein kinase inhibitor SB203580 is independent of p38MAPK activity. Endocrinology. 2005; 146(9):3773-81. DOI: 10.1210/en.2005-0404. View

3.
Sabio G, Davis R . cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance. Trends Biochem Sci. 2010; 35(9):490-6. PMC: 2975251. DOI: 10.1016/j.tibs.2010.04.004. View

4.
Taniguchi C, Aleman J, Ueki K, Luo J, Asano T, Kaneto H . The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinase-mediated insulin resistance. Mol Cell Biol. 2007; 27(8):2830-40. PMC: 1899914. DOI: 10.1128/MCB.00079-07. View

5.
Martin S, Parton R . Lipid droplets: a unified view of a dynamic organelle. Nat Rev Mol Cell Biol. 2006; 7(5):373-8. DOI: 10.1038/nrm1912. View